Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$240,075,629
+$88,107,571 QoQ
Shares Held
2,468,644
+29.4% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Dec 31, 2024CallValue
$13,848,084
CallShares
316,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Holocene Advisors, LP holds $1,357,789,985 across 26 Biotechnology names. RVMD ranks #1 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
This page
|
2,468,644 | $240,075,629 | |
| 2 | TERN |
Terns Pharmaceuticals, Inc.
|
4,115,828 | $216,986,452 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
733,905 | $138,744,740 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
1,890,927 | $92,957,971 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
1,518,686 | $88,311,590 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,250,196 | $86,610,044 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
3,932,603 | $82,270,054 | |
| 8 | BLTE |
Belite Bio, Inc
|
494,495 | $78,842,282 |
All Filings in RVMD
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240,075,629 | 2,468,644 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $151,968,058 | 1,907,948 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $160,521,116 | 3,437,283 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $133,656,304 | 3,632,952 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $130,540,067 | 3,691,744 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,848,084 | 316,600 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $131,076,095 | 2,996,710 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $97,482,591 | 2,149,561 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $85,516,825 | 2,203,474 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $78,074,306 | 2,422,411 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $82,660,205 | 2,882,155 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $60,639,184 | 2,190,722 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $58,263,105 | 2,178,060 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $45,590,357 | 2,104,818 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||